Baxter International Quarterly Financials On Target

Baxter International Inc. has announced financial results for the second quarter and confirmed its full-year 2012 financial outlook. Sales increase of 4% year-on-year coupled with 1% income hike is in line with previous guidance.

New International Boss For Baxter

Baxter International Inc. has announced that Jean-Luc Butel has been appointed corporate vice president and president, international and will assume his new role on February 20, 2012.

Baxter To Acquire Synovis

Baxter International Inc. and Synovis Life Technologies, Inc. have announced a definitive agreement for Baxter to acquire Synovis, a leading provider of biological and mechanical products for soft tissue repair used in a variety of surgical procedures.

Baxter Announces FDA Approval of ARTISS Fibrin Sealant For Use in Face-Lift (Facial Rhytidectomy) Procedures

Baxter International Inc. has announced that FDA has expanded the indication of ARTISS [Fibrin Sealant (Human)] to include adhering tissue flaps during facial rhytidectomy surgery (face-lift)

FDA Classifies Recent Urgent Device Correction on Baxter’s Colleague Infusion Pump as a Class I Recall

Baxter International Inc. announced today that the U.S. Food and Drug Administration has classified Baxter’s January 23, 2009 Urgent Device Correction letter to customers regarding U.S. COLLEAGUE® Volumetric Infusion Pumps as a Class I recall.